| Literature DB >> 28723483 |
Giovanni Cacciamani1, Carlos Fay2, Daniel Park2, Mohammed Alotaibi3, Inderbir S Gill4.
Abstract
We certainly agree with active surveillance for small renal masses 9SRMs). However, it must be in appropriate patients, the elderly and the infirm, in whom the comorbidity risks outweigh the oncologic risks. Evidence to support active surveillance for SRMs in the young is lacking.Entities:
Year: 2017 PMID: 28723483 PMCID: PMC9084473 DOI: 10.1016/j.euf.2017.02.011
Source DB: PubMed Journal: Eur Urol Focus ISSN: 2405-4569